Laxminarayan Bhat was appointed as the CEO of Reviva Pharmaceuticals Holdings, Inc. on August 1, 2026.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Laxminarayan Bhat was appointed as the CEO of Reviva Pharmaceuticals Holdings, Inc. on August 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Laxminarayan Bhat
researcher
Nothing else this week.